Details
Stereochemistry | RACEMIC |
Molecular Formula | C22H25NO3.ClH |
Molecular Weight | 387.9 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.O=C1OC(CCN2CCCCC2)OC1(C3=CC=CC=C3)C4=CC=CC=C4
InChI
InChIKey=JXNQXJVDHXGEPU-UHFFFAOYSA-N
InChI=1S/C22H25NO3.ClH/c24-21-22(18-10-4-1-5-11-18,19-12-6-2-7-13-19)26-20(25-21)14-17-23-15-8-3-9-16-23;/h1-2,4-7,10-13,20H,3,8-9,14-17H2;1H
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C22H25NO3 |
Molecular Weight | 351.4388 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Pipoxolan is an antispasmodic drug. In vivo, the drug inhibited the contractions of intestines caused by neostigmine, barium chloride or injection of acetylcholine. The drug possesses ganglioplegic action and inhibited the decrease in blood pressure caused by stimulation of the vagus nerve. The drug is marketed under tradename Rowapraxin worldwide for the treatment of spasms and colics in the gastrointestinal tract, gallbladder and urogenital area, bronchial spasms, spastic menstrual cramps. Recent studies have shown that pipoxalan has anticancer activity and inhibits proliferation of leukemia cells in animal models.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:1901080 Sources: https://www.ncbi.nlm.nih.gov/pubmed/5440391 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:53:16 GMT 2023
by
admin
on
Fri Dec 15 16:53:16 GMT 2023
|
Record UNII |
VIA6WM647S
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID5057672
Created by
admin on Fri Dec 15 16:53:16 GMT 2023 , Edited by admin on Fri Dec 15 16:53:16 GMT 2023
|
PRIMARY | |||
|
235861
Created by
admin on Fri Dec 15 16:53:16 GMT 2023 , Edited by admin on Fri Dec 15 16:53:16 GMT 2023
|
PRIMARY | RxNorm | ||
|
18174-58-8
Created by
admin on Fri Dec 15 16:53:16 GMT 2023 , Edited by admin on Fri Dec 15 16:53:16 GMT 2023
|
PRIMARY | |||
|
28931
Created by
admin on Fri Dec 15 16:53:16 GMT 2023 , Edited by admin on Fri Dec 15 16:53:16 GMT 2023
|
PRIMARY | |||
|
100000079705
Created by
admin on Fri Dec 15 16:53:16 GMT 2023 , Edited by admin on Fri Dec 15 16:53:16 GMT 2023
|
PRIMARY | |||
|
VIA6WM647S
Created by
admin on Fri Dec 15 16:53:16 GMT 2023 , Edited by admin on Fri Dec 15 16:53:16 GMT 2023
|
PRIMARY | |||
|
SUB14896MIG
Created by
admin on Fri Dec 15 16:53:16 GMT 2023 , Edited by admin on Fri Dec 15 16:53:16 GMT 2023
|
PRIMARY | |||
|
C170323
Created by
admin on Fri Dec 15 16:53:16 GMT 2023 , Edited by admin on Fri Dec 15 16:53:16 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110645
Created by
admin on Fri Dec 15 16:53:16 GMT 2023 , Edited by admin on Fri Dec 15 16:53:16 GMT 2023
|
PRIMARY | |||
|
m8866
Created by
admin on Fri Dec 15 16:53:16 GMT 2023 , Edited by admin on Fri Dec 15 16:53:16 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |